Morebio Company

  • Advanced Fermentation Platforms
  • Professional CDMO Service
  • GMP-Compliant Pharmaceutical Purity
Inquiry Now
What we do

CDMO Service

Morebio is a fully integrated CDMO provider with end-to-end service. We offer seamless development and manufacturing solutions from gene engineering and cell line development to the final aseptic finish. Our facilities are all GMP-compliant, ranging from small to large scale, to meet the diverse requirements of our clients.

GMP Capability
GMP Capacity
Advanced Manufacturing
Advanced Manufacturing
Quality Assurance
Quality Assurance
Quality Control
Quality Control
Stability Analysis
Stability Analysis
Project Management
Project Management
our team

Innovative Team

Morebio has the top genetic engineering and cytology technology team. Our core technical experts are:

Huimin Hou
Dr. Huimin Hou

CAE Academician

Formulation Expert

Xiaobing Fu
Dr. Xiaobing Fu

CAE Academician

NAE Member

Zesheng Wang
Dr. Zesheng Wang

President

Novel Drug Technical Expert

Wenxin Li
Dr. Wenxin Li

Virologist

Professor of Virology

Premium Service

Cellular Therapy

Morebio is a renowned contract development and manufacturing organization (CDMO) in China, specializing in the development of generic API for GLP-1 RAs. We cooperate with a broad range of customers from Asia, America, Europe, Middle East.

Driven by continuous innovation and operational excellence, we work closely with our clients to provide the flexibility and trust necessary for the future of biomanufacturing. As the sustainable CDMO partner, we focus on flexible manufacturing solutions, excellent operations, and proven expertise

Our Strategy

At Morebio, we have a vision to be the leader in the Chinese CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing.

  • High-performance team
  • Leading scientific, technological, and digital systems
  • Trust customer partnership
  • End-to-end execution excellence

Our core business includes generic APIs, recombinant proteases, and therapeutic cells.

Strategy

Our History

  • 2008 — Morebio is founded in 2008, specializing in peptide biological drugs.
  • 2011 — We achieved the award of High-tech Enterprise in Hubei, China.
  • 2011 — We establish the R&D center of Morebio-Wuhan University in active ingredients.
  • 2016 — Morebio set up the academician expert in Wuhan
  • 2016 — Morebio participates in 2 major projects of new national drug creation.
  • 2025 — A 13000 m2 digital GMP manufacturing center is built for China, USA, and EU GMP requirements.
History